Trimedx India Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 25-12-2024
- Paid Up Capital ₹ 12.19 Cr
as on 25-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 52.46%
(FY 2021)
- Profit 137.86%
(FY 2021)
- Ebitda 86.89%
(FY 2021)
- Net Worth 86.21%
(FY 2021)
- Total Assets -20.15%
(FY 2021)
About Trimedx India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 12.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Trimedx India Private Limited India is Chandrashekhara Alse as COMPANY SECRETARY. Christopher Dunkerley, Henry Hummel, and Nagarajan Anantharaman serve as directors at the Company.
- CIN/LLPIN
U85110KA2012FTC064138
- Company No.
064138
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
25 May 2012
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Trimedx India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekhara Alse  | Company Secretary | 25-Oct-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Christopher Dunkerley  | Director | 19-Jan-2018 | Current |
| Henry Hummel | Director | 19-Jan-2018 | Current |
| Nagarajan Anantharaman | Director | 27-Mar-2017 | Current |
Financial Performance of Trimedx India.
Trimedx India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 52.46% increase. The company also saw a substantial improvement in profitability, with a 137.86% increase in profit. The company's net worth Soared by an impressive increase of 86.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trimedx India?
In 2019, Trimedx India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trimedx India?
Trimedx India has a workforce of 80 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trimedx India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trimedx India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
